Literature DB >> 12597449

Validation and regulatory acceptance of new carcinogenicity tests.

Horst Spielmann1.   

Abstract

The 3 Rs concept, which was developed by Russell and Burch in 1959, was implemented into the legal framework in the European Union(EU) for the protection of vertebrate animals used for experimental and other scientific purposes, when Directive 86/609/EEC was adopted in 1986. To reduce or replace animal testing for regulatory purposes, nonanimal tests must be independently validated to prove that they can provide information that is relevant and reliable for hazard prediction in vivo. At the end of the 1980s, no scientific concept existed for the formal validation ofin vitro toxicity tests, so a small group of European and American scientists developed a set of principles for experimental validation, which was accepted internationally by the OECD in 1996. A major breakthrough was the acceptance in the EU of the scientifically validated in vitro toxicity test for phototoxic potential in 2000, which was accepted by the OECD at the worldwide level in 2002. Taking the progress in the development and validation of alternative toxicity tests during the past decade into account, the current concepts of developing alternatives to the standard 2-year rodent bioassay for carcinogenicity testing are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12597449     DOI: 10.1080/01926230390173897

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  2 in total

1.  Data mining in the U.S. National Toxicology Program (NTP) database reveals a potential bias regarding liver tumors in rodents irrespective of the test agent.

Authors:  Matthias Ring; Bjoern M Eskofier
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

2.  Meeting report: alternatives for developmental neurotoxicity testing.

Authors:  Pamela Lein; Paul Locke; Alan Goldberg
Journal:  Environ Health Perspect       Date:  2007-01-29       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.